Lucid Diligence Brief: China approves Boruik Kang (Neuracle) invasive BCI implant for paralysis
Lucid Diligence Brief: China approves Boruik Kang (Neuracle) invasive BCI…
Lucid Diligence Brief: Universal Health Services acquires Talkspace for $835 million
Lucid Diligence Brief: Universal Health Services acquires Talkspace for $835…
Lucid Diligence Brief: Enodia Therapeutics Kezar Sec61 deal
Lucid Diligence Brief: Enodia Therapeutics Kezar Sec61 deal Professional…
Lucid Diligence Brief: Agilent acquires Biocare Medical for $950 million
Lucid Diligence Brief: Agilent acquires Biocare Medical for $950 million…
Lucid Diligence Brief: Eli Lilly $500 million South Korea biopharma pledge
Lucid Diligence Brief: Eli Lilly $500 million South Korea biopharma pledge…
Lucid Diligence Brief: Medtronic / GE HealthCare patient monitoring alliance expansion
Lucid Diligence Brief: Medtronic / GE HealthCare patient monitoring alliance…
Lucid Diligence Brief: Cognito Therapeutics $105 million Series C
Lucid Diligence Brief: Cognito Therapeutics $105 million Series C Professional…
Lucid Diligence Brief: Tenaya Therapeutics and Alnylam Cardiovascular Collaboration
Lucid Diligence Brief: Tenaya Therapeutics and Alnylam Cardiovascular…
Lucid Diligence Brief: GAIA and Daiichi Sankyo Europe partnership on lipodia
Lucid Diligence Brief: GAIA and Daiichi Sankyo Europe partnership on lipodia…
Lucid Diligence Brief: Teva and Blackstone Life Sciences $400m duvakitug financing
Lucid Diligence Brief: Teva and Blackstone Life Sciences $400m duvakitug…
Lucid Diligence Brief: Poplar Therapeutics $95 million Series A
Lucid Diligence Brief: Poplar Therapeutics $95 million Series A extension…
Lucid Diligence Brief: OSE Immunotherapeutics refocus on lusvertikimab and Tedopi
Lucid Diligence Brief: OSE Immunotherapeutics refocus on lusvertikimab and…